| A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. MM Di Minno G, Coraggio F, Cerbone AM, Capitanio AM, Manzo C, Spina M ... The journal of clinical investigation 77 (1), 157-164, 1986 | 129 | 1986 |
| Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article A Mascolo, PM Berrino, P Gareri, A Castagna, A Capuano, C Manzo, ... Inflammopharmacology 26 (5), 1141-1149, 2018 | 97 | 2018 |
| Psychomotor agitation following treatment with hydroxychloroquine C Manzo, P Gareri, A Castagna Drug safety-case reports 4 (1), 6, 2017 | 43 | 2017 |
| Polymyalgia rheumatica as uncommon adverse event following immunization with Covid-19 vaccine: A case report and review of literature C Manzo, M Natale, A Castagna Aging Medicine (Milton), 2021 | 41 | 2021 |
| Increased level of serum HLA class I antigens in patient with systemic lupus erythematosus. Correlation with disease activity. A Bresciani, G Pirozzi, M Spera, ML Lombardi, L Ambrosone, S Migliaresi, ... Tissue antigens. 52 (1), 44-50, 1988 | 40* | 1988 |
| Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis C Manzo, M Milchert, M Natale, M Brzosko Rheumatology 58 (5), 921-923, 2019 | 29 | 2019 |
| Cognitive function in primary Sjögren’s syndrome: a systematic review C Manzo, E Martinez-Suarez, M Kechida, M Isetta, J Serra-Mestres Brain sciences 9 (4), 85, 2019 | 29 | 2019 |
| Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set C Manzo, M Natale Open Access Rheumatology: Research and Reviews, 93-95, 2016 | 27 | 2016 |
| The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica A Sobrero, C Manzo, A Stimamiglio Reumatismo 70 (1), 44-50, 2018 | 26 | 2018 |
| Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points … EM Schiavone, CL Pardo, RD Noto, C Manzo, F Ferrara, C Vacca, ... British journal of haematology 91 (4), 899-906, 1995 | 24 | 1995 |
| Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease. C Manzo, D Camellino Recenti Progressi in Medicina 108 (5), 221-231, 2017 | 23 | 2017 |
| Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case C Manzo Medical Sciences 7 (9), 92, 2019 | 22 | 2019 |
| Diagnosis of polymyalgia rheumatica in primary health care : favoring and confounding factors - a cohort study. C Manzo, M Natale, E Traini Reumatologia 56 (3), 131-139, 2018 | 22 | 2018 |
| Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? C Manzo, J Serra-Mestres, M Isetta, A Castagna Medical Hypotheses 147, 110479, 2021 | 20 | 2021 |
| Behavioral, psychiatric, and cognitive adverse events in older persons treated with glucocorticoids C Manzo, J Serra-Mestres, A Castagna, M Isetta Medicines 5 (3), 82, 2018 | 18 | 2018 |
| Absence of elevated creatine kinase in dermatomyiositis does not exclude malignancy. G La Montagna, C Manzo, E Califano, R Tirri Scandinavian Journal of Rheumatology 17 (1), 73-74, 1988 | 17 | 1988 |
| Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? C Manzo, A Castagna, G Ruotolo Joint Bone Spine 88 (3), 105150, 2021 | 16 | 2021 |
| Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis: a four-point guidance C Manzo, M Milchert Reumatologia/Rheumatology 56 (1), 1-2, 2018 | 16 | 2018 |
| Polymyalgia rheumatica in association with remitting seronegative sinovitis with pitting edema: a neoplastic warning C Manzo, M Natale Canadian Geriatrics Journal 20 (2), 94, 2017 | 16 | 2017 |
| Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas … C Manzo, M Isetta, M Natale, A Castagna Medicines (Basel) 7 (11), 68, 2020 | 15 | 2020 |
Marcin MilchertMD, PhD, Pomeranian Medical University in Szczecin, PolandEmail verificata su spsk1.szn.pl
